Skip to search boxSkip to navigationSkip to main content

Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-b1/smad and myocardin/serum response factor

  • Jinjing Zhao
    ,
  • Wen Wu
    ,
  • Wei Zhang
    ,
  • Yao Wei Lu
    ,
  • Emiley Tou
    ,
  • Jiemei Ye
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Tetraspanins (TSPANs) comprise a large family of 4-trans membr anedoma in proteins. Theimportance of TSPANs in vascular smoothmuscle cells (VSMCs) is unexplored. Given that TGF-β1 and myocardin (MYOCD) are potent activators for VSMC differentiation, we screened for TGF-β1 and MYOCD/serum response factor (SRF)-regulated TSPANs in VSMC by using RNA-seqanalyses and RNA-arrays. TSPAN2was found to be the only TSPAN family gene induced by TGF-β1 and MYOCD, and reduced by SRF deficiency in VSMCs. We also found that TSPAN2 is highly expressed in smooth muscle-enriched tissues and down-regulated in in vitro models of VSMC pheno typi cmodulation. TSPAN2expressionis attenuatedinmouse carotid arteries after ligationinjury and infailed human arteriovenous fistula samples after occlusion by dedifferentiated neointimal VSMC. In vitro functional studies showed that TSPAN2 suppresses VSMC proliferation and migration. Luciferase reporter and chromatin immunopreci pitation assays demonstrated that TSPAN2 is regulated by 2 parallel pathways, MYOCD/SRF and TGF-β1/SMAD, via distinct binding elements within the proximal promoter. Thus, we identified the first VSMCenriched and MYOCD/SRF and TGF-β1/SMAD-dependent TSPAN familymember, whose expression is intimately associated with VSMC differentiation and negatively correlated with vascular disease. Our results suggest that TSPAN2mayplay important roles in vasculardisease.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2576-2591 (16 pages)

Journal (Volume, Issue Number)

FASEB Journal (Volume 31, Issue 6)

Publication milestones

  • Published - 06/2017

Publication status

Published - 06/2017

ISSN

0892-6638

Publication IDs

  • Scopus: 85020292336
  • PubMed: 28258189
  • ORCID: /0000-0002-2077-3188/work/117466073

Publication metrics

Metrics

Fractional count
2
Fractional count
0.18
Fractional count
9
Fractional count
0.82
Fractional count
2
Fractional count
1
SciVal
FWCI
0.74
SciVal
Author count
11
SciVal
citations
12
SciVal
Paper percentile
79
Scopus
citations

PlumX, opens in new tab

Citation count
29
Captures
24

Funding Details

FunderFunding number
NHLBI
R01HL121700